Bull & Lifshitz, LLP announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of Synovis Life Technologies, Inc. (Nasdaq: SYNO) (referred to as "Synovis" or the “Company”) to Baxter International Inc. (“Baxter”) in a cash transaction valued at approximately $325 million of equity value or $260 million, after adjusting for the net cash.

Under the terms of the merger agreement, at the effective time of the merger (the "Effective Time"), each share of common stock this is issued and outstanding immediately prior to the Effective Time (other than Synovis common stock owned directly or indirectly by Baxter or any subsidiary of Synovis, which shall be cancelled without payment of any consideration, and Synovis common stock for which dissenters' rights have been validly exercised and not withdrawn) will be converted at the Effective Time into the right to receive $28.00 in cash.

Bull & Lifshitz, LLP's investigation is focused on whether the proposed deal provides adequate value to the Company’s shareholders.

If you are a holder of Synovis common stock and want to discuss your legal rights, you may e-mail or call Bull & Lifshitz, LLP who will, without obligation or cost to you, attempt to answer your questions.

If you are a shareholder of Synovis and would like more information about our investigation, please contact Peter D. Bull, Esq. by telephone at (866) 313-6222 or by sending an e-mail including your contact information to: counsel@nyclasslaw.com. All e-mail correspondence should make reference to Synovis.

Bull & Lifshitz, LLP is a New York City-based law firm with significant experience representing investors in merger-related shareholder class actions, shareholder derivative actions, and securities fraud class actions. For more information about the firm, please visit our website at www.nyclasslaw.com.

ATTORNEY ADVERTISING . © 2011 Bull & Lifshitz, LLP. The law firm responsible for this advertisement is Bull & Lifshitz, LLP, 18 East 41 st Street, New York, New York 10017, (212) 213-6222. Prior results do not guarantee or predict a similar outcome with respect to any future matter .

Copyright Business Wire 2010